San Diego genomics toolkit startup snags $55 million to advance 'big DNA'
Replay has developed technology platforms to help jumpstart emerging gene and cell therapies.
Stay updated with breaking news from Base Genomics. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Replay has developed technology platforms to help jumpstart emerging gene and cell therapies.
Press release content from Globe Newswire. The AP news staff was not involved in its creation.
Replay Launches with $55 Million Seed to Reprogram Biology by Writing and Delivering Big DNA KKR and OMX Ventures lead $55 million seed funding...
SVB Leerink has decided to maintain its Outperform rating of Exact Sciences (NASDAQ:EXAS) and lower its price target from $130.00 to $95.00. Share...
/PRNewswire/ -- Oxford Science Enterprises, the Science Business Builder and preferred intellectual property partner of the University of Oxford, today...